EFFECTIVENESS OF HTLV-III ANTIBODY SCREENING
EFFECTIVENESS OF HTLV-III ANTIBODY SCREENING
批准号:
2312864
负责人:
GIRISH N VYAS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-30 至 1995-09-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of this project is to develop a flow cytometry detection system
(FCDS) for human lymphocytes infected with HIV-1. Optimal conditions
for fixation have been established; these not only delineate the
presence of intracellular HIV, but also result in inactivation of
infectious HIV. Furthermore, primary and secondary antibody reactions
have also been characterized. The primary antibody is specific for p24,
and the secondary antibody consists of the f(ab')2 fragment of a
fluorescein-conjugated, goat anti-mouse immunoglobulin antibody. The
system is sensitive enough to detect one HIV-infected cell in 10,000
uninfected cells in experimentally infected human T-lymphoid cell lines.
The FCDS is currently being used to examine samples from people known to
be at high risk of HIV infection (hemophiliacs and their sexual
partners) and from randomly selected blood donors. The system has also
been modified to include the use of leu M3 phycoerythrin-labelled
monoclonal antibody (CD14) for identifying infected monocytes. Low
levels of apparently positive cells have been detected in the leu M3
negative cells. Experiments are currently under way to identify whether
or not these cells are infected with HIV.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Human immunodeficiency virus seroprevalence among blood product recipients in San Francisco before transfusion.
旧金山血液制品接受者输血前人类免疫缺陷病毒血清阳性率。
DOI:
10.1046/j.1537-2995.1989.29289146827.x
发表时间:
1989
期刊:
Transfusion
影响因子:
2.9
作者:
[Hwang,LY, Beasley,RP, Busch,MP, Lane,PK, Vyas,GN]
通讯作者:
Vyas,GN
Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase.
在丙氨酸氨基转移酶升高的血清阴性供体中,通过聚合酶链反应很少检测到乙型肝炎和丙型肝炎病毒基因组。
DOI:
10.1046/j.1537-2995.1994.34894353458.x
发表时间:
1994
期刊:
Transfusion
影响因子:
2.9
作者:
[Sankary,TM, Yang,G, Romeo,JM, Ulrich,PP, Busch,MP, Rawal,BD, Vyas,GN]
通讯作者:
Vyas,GN
Absence of HIV-1 DNA in high-risk seronegative individuals using high-input polymerase chain reaction.
使用高输入聚合酶链反应检测高危血清阴性个体中 HIV-1 DNA 的缺失。
DOI:
10.1097/00002030-199110000-00008
发表时间:
1991
期刊:
AIDS (London, England)
影响因子:
--
作者:
[Lee,TH, el-Amad,Z, Reis,M, Adams,M, Donegan,EA, O'Brien,TR, Moss,AR, Busch,MP]
通讯作者:
Busch,MP
Resolution of infection status of human immunodeficiency virus (HIV)-seroindeterminate donors and high-risk seronegative individuals with polymerase chain reaction and virus culture: absence of persistent silent HIV type 1 infection in a high-prevalence a
通过聚合酶链反应和病毒培养解决人类免疫缺陷病毒 (HIV) 血清不确定供体和高危血清阴性个体的感染状态:高流行率中不存在持续性静默 HIV 1 型感染
DOI:
10.1046/j.1537-2995.1992.32692367191.x
发表时间:
1992
期刊:
Transfusion
影响因子:
2.9
作者:
[Eble,BE, Busch,MP, Khayam-Bashi,H, Nason,MA, Samson,S, Vyas,GN]
通讯作者:
Vyas,GN
Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay.
使用重组抗原免疫印迹测定对人类免疫缺陷病毒 1 型抗体进行可靠的确认和定量。
DOI:
10.1046/j.1537-2995.1991.31291142943.x
发表时间:
1991
期刊:
Transfusion
影响因子:
2.9
作者:
[Busch,MP, elAmad,Z, McHugh,TM, Chien,D, Polito,AJ]
通讯作者:
Polito,AJ
共 8 条
IN VITRO INACTIVATION OF VIRUSES IN BLOOD COMPONENTS
-
批准号:2771386
-
项目类别:
-
资助金额:$42.87万
-
财政年份:1994
-
负责人:GIRISH N VYAS
-
依托单位:
IN VITRO INACTIVATION OF VIRUSES IN BLOOD COMPONENTS
-
批准号:2519450
-
项目类别:
-
资助金额:$41.28万
-
财政年份:1994
-
负责人:GIRISH N VYAS
-
依托单位:
IN VITRO INACTIVATION OF VIRUSES IN BLOOD COMPONENTS
-
批准号:2231266
-
项目类别:
-
资助金额:$38.03万
-
财政年份:1994
-
负责人:GIRISH N VYAS
-
依托单位:
IN VITRO INACTIVATION OF VIRUSES IN BLOOD COMPONENTS
-
批准号:2231267
-
项目类别:
-
资助金额:$39.83万
-
财政年份:1994
-
负责人:GIRISH N VYAS
-
依托单位:
IN VITRO INACTIVATION OF VIRUSES IN BLOOD COMPONENTS
-
批准号:2231265
-
项目类别:
-
资助金额:$36.56万
-
财政年份:1994
-
负责人:GIRISH N VYAS
-
依托单位:
REMOVAL/INACTIVATION OF VIRUSES IN BLOOD
-
批准号:3359113
-
项目类别:
-
资助金额:$32.49万
-
财政年份:1988
-
负责人:GIRISH N VYAS
-
依托单位:
REMOVAL/INACTIVATION OF VIRUSES IN BLOOD
-
批准号:3359112
-
项目类别:
-
资助金额:$38.14万
-
财政年份:1988
-
负责人:GIRISH N VYAS
-
依托单位:
REMOVAL/INACTIVATION OF VIRUSES IN BLOOD
-
批准号:3359110
-
项目类别:
-
资助金额:$39.14万
-
财政年份:1988
-
负责人:GIRISH N VYAS
-
依托单位:
TRANSFUSION-RELATED VIRAL INFECTIONS AND IMMUNE RESONSE
-
批准号:3098542
-
项目类别:
-
资助金额:$84.6万
-
财政年份:1986
-
负责人:GIRISH N VYAS
-
依托单位:
EFFECTIVENESS OF HTLV-III ANTIBODY SCREENING
-
批准号:2312853
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1986
-
负责人:GIRISH N VYAS
-
依托单位:
DEVELOPMENT OF SCREENING TESTS FOR HTLV-III
-
批准号:3645682
-
项目类别:
-
资助金额:$16.21万
-
财政年份:1986
-
负责人:GIRISH N VYAS
-
依托单位:
TRANSFUSION-RELATED VIRAL INFECTIONS AND IMMUNE RESPONSE
-
批准号:3098546
-
项目类别:
-
资助金额:$1.31万
-
财政年份:1986
-
负责人:GIRISH N VYAS
-
依托单位:
EFFECTIVENESS OF HTLV-III ANTIBODY SCREENING
-
批准号:2312856
-
项目类别:
-
资助金额:$108.56万
-
财政年份:1986
-
负责人:GIRISH N VYAS
-
依托单位:
EFFECTIVENESS OF HTLV-III ANTIBODY SCREENING
-
批准号:2312859
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1986
-
负责人:GIRISH N VYAS
-
依托单位:
DEVELOPMENT OF SCREENING TESTS FOR HTLV-III
-
批准号:3645684
-
项目类别:
-
资助金额:$130.98万
-
财政年份:1986
-
负责人:GIRISH N VYAS
-
依托单位:
EFFECTIVENESS OF HTLV-III ANTIBODY SCREENING
-
批准号:2312854
-
项目类别:
-
资助金额:$102.79万
-
财政年份:1986
-
负责人:GIRISH N VYAS
-
依托单位:
EFFECTIVENESS OF HTLV-III ANTIBODY SCREENING
-
批准号:2312863
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1986
-
负责人:GIRISH N VYAS
-
依托单位:
TRANSFUSION RELATED VIRAL INFECTIONS AND IMMUNE RESPONSE
-
批准号:3098549
-
项目类别:
-
资助金额:$93.08万
-
财政年份:1986
-
负责人:GIRISH N VYAS
-
依托单位:
TRANSFUSION RELATED VIRAL INFECTIONS AND IMMUNE RESPONSE
-
批准号:3098545
-
项目类别:
-
资助金额:$5.29万
-
财政年份:1986
-
负责人:GIRISH N VYAS
-
依托单位:
DEVELOPMENT OF SCREENING TESTS FOR HTLV-III
-
批准号:3645689
-
项目类别:
-
资助金额:$5.07万
-
财政年份:1986
-
负责人:GIRISH N VYAS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HTLV-1病毒通过调控细胞应激颗粒抑制天然免疫并促进病毒复制的机制研究
-
批准号:32370147
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:赵铁军
-
依托单位:
PCBP1在HTLV-1感染诱导炎症和致癌过程中的调控作用及其机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:苏芮
-
依托单位:
B细胞在HTLV-1相关脊髓病的作用及机制研究
-
批准号:U22A20296
-
项目类别:联合基金项目
-
资助金额:255.00万元
-
批准年份:2022
-
负责人:林毅
-
依托单位:
HTLV-1病毒通过HBZ-miR455-AK4/RHOC途径促进白血病发生的分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:马广勇
-
依托单位:
B23与人类T淋巴细胞白血病病毒1型(HTLV-1)HBZ相互作用及其发病机制研究
-
批准号:81902076
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:刘振龙
-
依托单位:
Ku70负性调控HTLV-1病毒感染的功能和机制研究
-
批准号:U1504811
-
项目类别:联合基金项目
-
资助金额:27.0万元
-
批准年份:2015
-
负责人:王洁
-
依托单位:
HTLV-1 TAX 持续性激活 IKK-NF-κB的机制探讨
-
批准号:31571445
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2015
-
负责人:夏总平
-
依托单位:
MHC Ⅱ类分子HLA-DM在HTLV-1复制过程中的功能和机制研究
-
批准号:31400776
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2014
-
负责人:杨波
-
依托单位:
Bcl3对HTLV-1病毒感染细胞内NFκB通路和细胞自噬作用的分子机制
-
批准号:81471559
-
项目类别:面上项目
-
资助金额:75.0万元
-
批准年份:2014
-
负责人:王辉
-
依托单位:
Sirt1维持HTLV-1感染T细胞持续性潜伏的作用及分子机制
-
批准号:81373135
-
项目类别:面上项目
-
资助金额:75.0万元
-
批准年份:2013
-
负责人:朱小飞
-
依托单位: